This course has expired. View available courses.
Oncology
Module 1 : Prostate cancer – Screening and supporting your patients through treatment
Cancer is the leading cause of death of Canadians. An estimated 2 in 5 Canadians will be diagnosed with cancer in their lifetime and approximately 1 in 4 will die from it. Management advancements has led to improved outcomes and quality of life for oncology patients. With screening and early-stage diagnosis being so fundamental to survival and optimal outcomes, primary care clinicians play a key role in identification and screening patients at risk. These clinicians also play an important role in supporting these patients before, during and after active cancer treatment.
DURATION
1 hr
PROFESSION
Physician, Specialist
# OF CREDITS
1
ACCREDITATION
Mainpro+
EXPIRY DATE
2024-09-23
Cancer is the leading cause of death of Canadians. An estimated 2 in 5 Canadians will be diagnosed with cancer in their lifetime and approximately 1 in 4 will die from it. Management advancements has led to improved outcomes and quality of life for oncology patients. With screening and early-stage diagnosis being so fundamental to survival and optimal outcomes, primary care clinicians play a key role in identification and screening patients at risk. These clinicians also play an important role in supporting these patients before, during and after active cancer treatment.
This program has received an unrestricted educational grant or in-kind support from AstraZeneca and Novartis
Faculty
Moderator:
- James Kim, MD, MCFP, MBBch, Pg Dip (Diabetes), MScCH(HPTE)
Speaker:
- Peter Lin, MD, CCFP
Oncologist:
- Sharlene Gill, BSc (Pharm), MD, MPH, MBA, FACP, FRCP(C)
Learning objectives
After completion of the webinar participants will be better able to:
- Discuss the prevalence and risk factors of people with prostate cancer
- Determine the guideline-recommended methods of screening for prostate cancer
- Manage a patient with prostate cancer who is experiencing adverse effects from their treatment
- Recommend the appropriate follow-up and monitoring of patients with prostate cancer
Accreditation
This Self-Learning program has been certified by the College of Family Physicians of Canada for up to 1.0 Mainpro+ Credit(s).
Cert+ Program ID#: 199854.
This program is developed in collaboration with Partners in Progressive Medical Education (PPME).
#
of credits: 1
Duration: 1 hr
FAQs & HELP
MDBriefCase Group specializes in accredited, online continuing professional development (CPD) programs, custom tailored for specific international markets and available on a convenient online platform.
All content is developed by leading specialists and peer-reviewed by experts at respected institutions, which keeps more than 280,000 global healthcare professionals at the forefront of the latest evidence and protocols worldwide.
The vast majority of our programs are accredited by one or more respected institutions. We do provide unaccredited content to ensure that healthcare professionals have access to relevant practical resources in addition to accredited learning.
Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.
MDBriefCase Group works with various institutions to provide peer-reviewed, up-to-date accredited content. Our programs and resources are provided via collaboration between medical writers, faculty members, associations, universities and other relevant organizations. The content you were recommended is likely valued by your society or association and is conveniently provided to you free of charge on an MDBriefCase Group platform.
Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.
If you are interested in learning more about supporting one of our programs, please contact us.
If you are interested in working with MDBriefCase Group as a writer or committee member, please contact us.
To access the MDBriefCase Group privacy policy, please click here.
No, registration with MDBriefCase is free!
To access your profile, visit My Profile. If you would like to update the information here don’t forget to hit the ‘save’ button when you are finished. Your profile is where you can control what email communications you receive.
If you have forgotten your password, you can reset your password. To access this page from the Login page, click Forgot password. Enter the email address you registered with and you will receive an email with a link to reset your password.
Please note: if you submitted multiple password resets, only the link on the most recent email is valid.
You can unsubscribe from MDBriefCase Group emails by clicking the unsubscribe button located at the bottom of each of our emails.
1 hr
Duration
Physician, Specialist
Profession
1
# of credits
Learning Objectives
After completion of the webinar participants will be better able to:
- Discuss the prevalence and risk factors of people with prostate cancer
- Determine the guideline-recommended methods of screening for prostate cancer
- Manage a patient with prostate cancer who is experiencing adverse effects from their treatment
- Recommend the appropriate follow-up and monitoring of patients with prostate cancer
Mainpro+
ACCREDITATION
Oncology
Learning Category
Prostate Cancer
Topic
0
Price
2024-09-23
Expiry Date
CAN-eng
Region/Language
Course Description
Cancer is the leading cause of death of Canadians. An estimated 2 in 5 Canadians will be diagnosed with cancer in their lifetime and approximately 1 in 4 will die from it. Management advancements has led to improved outcomes and quality of life for oncology patients. With screening and early-stage diagnosis being so fundamental to survival and optimal outcomes, primary care clinicians play a key role in identification and screening patients at risk. These clinicians also play an important role in supporting these patients before, during and after active cancer treatment.
This program has received an unrestricted educational grant or in-kind support from AstraZeneca and Novartis
Faculty
Moderator:
- James Kim, MD, MCFP, MBBch, Pg Dip (Diabetes), MScCH(HPTE)
Speaker:
- Peter Lin, MD, CCFP
Oncologist:
- Sharlene Gill, BSc (Pharm), MD, MPH, MBA, FACP, FRCP(C)
Accreditation
This Self-Learning program has been certified by the College of Family Physicians of Canada for up to 1.0 Mainpro+ Credit(s).
Cert+ Program ID#: 199854.
This program is developed in collaboration with Partners in Progressive Medical Education (PPME).
1 hr
Duration
0
Price
1
# of credits
